fluphenazine has been researched along with Glioblastoma in 1 studies
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berghauser Pont, LM | 1 |
| Balvers, RK | 1 |
| Kloezeman, JJ | 1 |
| Nowicki, MO | 1 |
| van den Bossche, W | 1 |
| Kremer, A | 1 |
| Wakimoto, H | 1 |
| van den Hoogen, BG | 1 |
| Leenstra, S | 1 |
| Dirven, CM | 1 |
| Chiocca, EA | 1 |
| Lawler, SE | 1 |
| Lamfers, ML | 1 |
1 other study available for fluphenazine and Glioblastoma
| Article | Year |
|---|---|
In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluphenazine; Glioblastoma; HCT116 | 2015 |